1Greefield LJ, Michana BA. Twenty-year experience with the greenfield veva caval filter[J]. Surgery, 1988 ; 104:706-7.
2Vedantham S, Millward SF, Cardella JF, et al. Society of interventional radiology position statement : treatment of acute iliofemoral deep vein thrombosis with use of adjunctive catheter-directed thrombolysis[J]. J Vasc Interv Radio,2006;17(4) :613-6.
4Bates SM, Ginsberg JS. Treatment of deep-vein thrombosis[J]. N Engl J Med,2004 ;351 ( 3 ) :268-77.
5Chaer RA, Dayal R, Lin SC,et al. Multimodal therapy for acute and chronic venous thrombotic and occlusive disease [J]. Vasc Endovasc Surg, 2005 ; 39 ( 5 ) : 375-80.
6Krupski WC, Bass A, Dilley RB,et al. Propagation of deep venous thrombosis identified by duplex uhrasonography [J]. J Vasc Surg, 1990; 12: 467-75.
7Akesson H, Brudin L, Dahlstrom JA,et al. Venous function assessed during a five year period after acute iliofemoral venous thrombosis treated with anticoagulation[J]. Eur J Vasc Surg, 1990;4:43-8.
8Elsharawy M, Elzayat E. Early results of thrombolysis vs antieoagulation in iliofemoral venous thrombosis A randomized clinical trial [J]. Eur J Vasc Surg,2002 ;24:209-14.
9Ost D ,Tepper J, Mihara H ,et al. Duration of anticoagulation following venous thromboembolism [J]. JAMA,2005 ;294 (6) :706-16.
10Howk,Hankey GJ,Quinlan DJ,et al. Risk of recurrent venous thromboembolism in patients with common thrombophilia[J]. Arch Intern Med, 2006 ; 166 ( 4 ) : 729-36.
二级参考文献8
1Cockett FB and Thomal ML. The iliac compression syndrome. Brit J Surg, 1965, 52:816-821.
2Becquemin JP, Juillet Y, Mexme M, et al. Clinical presentations of Cocketts syndrome: 16 cases. Nouv Press Med, 1981, 70:959.
3Friedrich JM, Hutschenreiter S, Mickley V, et al. Stent-supported percutaneous therapy of illac vein stenosis following operative thrombectomy and placement of a shunt. Rofo Fortschr Geb Rontgenstr Neuen Bildgb, 1992,157:591.
10Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with maligenancy versus those without malignancy. Risk analysis using Medicare claims data[ J]. Medicine(Baltimore) , 1999,78 (5) :285-291.
